Testing a contactless device for home blood pressure checks in hypertension
Compares a contactless monitor with a cuff for home blood pressure in adults.
Plain-language title generated from the registry record
Registry title: Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care
Key facts
- Where
- London, United KingdomSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT06325384, who can take part
Where in United Kingdom
- William Harvey Heart Centre, Queen Mary Queen Mary University of London, Charterhouse Square,London, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xim Limited
- Trial code
- NCT06325384
- Record updated
- 3 April 2025
- Original description
A randomised controlled trial for comparison of real-world feasibility and clinical outcomes of two different methods of home blood pressure monitoring Participants aged 18 years or over with diagnosed and treated hypertension (including via lifestyle interventions) that is not controlled (i.e. in-clinic measurement is 140/90 mmHg or greater) will be recruited from hypertension hospital clinicsRead full original descriptionShow less
VISION-Real World Evaluation
A randomised controlled trial for comparison of real-world feasibility and clinical outcomes of two different methods of home blood pressure monitoring Participants aged 18 years or over with diagnosed and treated hypertension (including via lifestyle interventions) that is not controlled (i.e. in-clinic measurement is 140/90 mmHg or greater) will be recruited from hypertension hospital clinics
Inclusion: 18 years or older; Established diagnosis of hypertension; Uncontrolled hypertension defined as office blood pressure ≥140/90mmHg; Patients who are pharmacologically treated for their hypertension should have been on stable medication for at least 4 weeks; Ability to read, write and understand English to complete the study; Capacity to give free, valid informed consent; A compatible device that supports Lifelight®, as per xim Ltd.'s constantly updating list of compatible devices. If this is not possible, xim Ltd, might provide a similar device for the purpose of the study.
Exclusion: Patients with stage III hypertension with office blood pressure ≥180/120mmHg or it is unsafe to keep them in the study, in the opinion of the investigators; Patients with significant arrhythmias such as SVT (Supraventricular tachycardia) or any rhythm that has significant impact on their BP, poor perfusion, pregnancy, pre-eclampsia, deformities or abnormalities which may prevent proper application of a BP cuff, or skin disorders (anaemia, jaundice, rosacea, psoriasis, acute acne, and erythropoietic protoporphyria); Patients on dialysis or known ESRD (End-stage kidney disease); Patients on active cancer treatment; Individuals with diagnosed atrial fibrillation; Participants who are unwilling to undertake self-monitoring or lacking capacity; Partners or spouses of individuals already randomised in the trial; Terminally ill patients; Patients who cannot tolerate sitting for up to one hour.